Bridgewater Bancshares, Inc.
Bridgewater Bancshares, Inc. (BWB) Financial Performance & Income Statement Overview
Analyze Bridgewater Bancshares, Inc. (BWB) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Bridgewater Bancshares, Inc. (BWB) Income Statement & Financial Overview
Explore comprehensive income reports for Bridgewater Bancshares, Inc. BWB, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $67.34M | $65.43M | $64.17M | $62.11M |
| Cost of Revenue | $37.00M | $38.53M | $37.43M | $36.48M |
| Gross Profit | $30.34M | $26.90M | $26.74M | $25.63M |
| Gross Profit Ratio | $0.45 | $0.41 | $0.42 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $12.15M | $11.69M | $10.97M | $10.72M |
| Operating Expenses | $17.68M | $16.39M | $15.38M | $15.01M |
| Total Costs & Expenses | $54.69M | $54.92M | $52.81M | $51.49M |
| Interest Income | $65.71M | $63.32M | $63.03M | $60.88M |
| Interest Expense | $35.50M | $36.36M | $37.43M | $35.88M |
| Depreciation & Amortization | $1.43M | $1.09M | $598000.00 | $571000.00 |
| EBITDA | $14.08M | $11.61M | $11.96M | $11.19M |
| EBITDA Ratio | $0.21 | $0.18 | $0.19 | $0.18 |
| Operating Income | $12.65M | $10.51M | $11.36M | $10.62M |
| Operating Income Ratio | $0.19 | $0.16 | $0.18 | $0.17 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $12.65M | $10.51M | $11.36M | $10.62M |
| Income Before Tax Ratio | $0.19 | $0.16 | $0.18 | $0.17 |
| Income Tax Expense | $3.02M | $2.31M | $2.69M | $2.50M |
| Net Income | $9.63M | $8.20M | $8.68M | $8.12M |
| Net Income Ratio | $0.14 | $0.13 | $0.14 | $0.13 |
| EPS | $0.31 | $0.26 | $0.28 | $0.26 |
| Diluted EPS | $0.31 | $0.26 | $0.27 | $0.26 |
| Weighted Avg Shares Outstanding | $27.57M | $27.46M | $27.38M | $27.39M |
| Weighted Avg Shares Outstanding (Diluted) | $28.04M | $28.06M | $27.91M | $27.75M |
The company's financials show resilient growth, with revenue advancing from $62.11M in Q2 2024 to $67.34M in Q1 2025. Gross profit remained healthy with margins at 45% in Q1 2025 compared to 41% in Q2 2024. Operating income hit $12.65M last quarter, sustaining a consistent 19% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $14.08M. Net income rose to $9.63M, while earnings per share reached $0.31. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan